MAPK3 and hematocrit: A recent study demonstrated that a Chinese patent medicine decreased both levels of TgAb and TPOAb, and alleviated lymphocytic infiltration by regulating expressions of p-ERK1/2 in a rat model [39], which further highlighted the crucial role of ERK1/2 signals in the HT progression.